Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 22
Phase 32
Phase 42

Trial Status

Completed8

Role Distribution

Other Roles8

Activity Timeline

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Valeant Pharmaceuticals

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (8)

Showing 8 of 8 trials

NCT03168334Phase 3StudyDirector

A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (302)

Acne Vulgaris
Completed
NCT03168321Phase 3StudyDirector

A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (301)

Acne Vulgaris
Completed
NCT02849873Phase 1StudyDirector

Absorption and Systematic Pharmacokinetics of IDP-123 Lotion in Comparison With Tazorac Cream

Acne
Completed
NCT02767947Phase 4StudyDirector

Safety and Efficacy of Product 33525 (Luliconazole Cream 1%) in Pediatric Participants With Tinea Corporis

Tinea Corporis
Completed
NCT02767271Phase 4StudyDirector

Maximal Use of Luliconazole Cream 1% in Pediatric Participants With Moderate to Severe Tinea Pedis or Tinea Cruris

Tinea CrurisTinea Pedis
Completed
NCT03003247Phase 2StudyDirector

Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris

Acne Vulgaris
Completed
NCT02850003Phase 1StudyDirector

Absorption and Systematic Pharmacokinetics of Topically Applied IDP-120 Gel

Acne
Completed
NCT02938494Phase 2StudyDirector

Safety and Efficacy of IDP-123 Lotion to Tazorac® Cream, in the Treatment of Acne Vulgaris

Acne Vulgaris
Completed

All 8 trials loaded